UAB Medicine Hematology and Oncology Highlights 2021


 

2021 Updates in Leukemia: Ponatinib + Blinatumomab in Ph+ ALL, KRT-X19 in R/R B-ALL, Aspacytarabine in Newly Diagnosed AML

14 views
September 9, 2021
0 Comments
Login to view comments. Click here to Login
Videos